Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q4VG
|
||||
Former ID |
DNC007267
|
||||
Drug Name |
4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527327] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H17ClN2O
|
||||
Canonical SMILES |
CCCCN1C2=C(C=CC=C2Cl)C(=C3C=CC(=O)C=C3)N1
|
||||
InChI |
1S/C17H17ClN2O/c1-2-3-11-20-17-14(5-4-6-15(17)18)16(19-20)12-7-9-13(21)10-8-12/h4-10,19H,2-3,11H2,1H3
|
||||
InChIKey |
FLFPFWKHGXKNNT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [527327] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.